It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A potent antibacterial drug was developed by synthesizing a set of new pyrazoles substituted oxazole derivatives using multi-step synthesis. FT-IR, 1H-NMR, Mass spectroscopy, and bases of microanalyses are employed to confirm the structure of compounds. Molinspiration online tool was used to predict the molecular properties and molecular docking was used to predict the antitubercular potency of the target compounds. 10-Fold serial dilution method, agar streak dilution test, and DPPH radical scavenging methods are utilized to evaluate antitubercular, antibacterial, and radical scavenging properties of test compounds and reference drugs, respectively. Varying degree of antitubercular, antibacterial, and radical scavenging activities (mild to good) was displayed by synthesized oxazole compounds. In general, unsubstituted oxazole derivatives exhibited superior antibacterial potency than substituted analogs. In addition, meta-substituted analogs displayed higher activity than the corresponding para-substituted analogs. Among fifteen tested target compounds, the potent compound of this series was found to be 4-(4-(5-phenyl- 4,5-dihydro-1H-pyrazol-3-yl)benzylidene)-2-methyloxazol-5(4H)-one (PBO8). Hence, this analog may be used as a lead molecule to find potent & safer antibacterial agents.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer





